Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer

Clinical trial NCT06122584 · RECRUITING

Trial details

NCT number: NCT06122584
Sponsor: ABX advanced biochemical compounds GmbH
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2024-06-13
Primary completion: 2027-03-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.